These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21063687)

  • 1. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research.
    Fatta-Kassinos D; Meric S; Nikolaou A
    Anal Bioanal Chem; 2011 Jan; 399(1):251-75. PubMed ID: 21063687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
    Daughton CG
    Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
    Huerta B; Rodríguez-Mozaz S; Barceló D
    Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
    Klecka G; Persoon C; Currie R
    Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes - degradation, elucidation of byproducts and assessment of their biological potency.
    Fatta-Kassinos D; Vasquez MI; Kümmerer K
    Chemosphere; 2011 Oct; 85(5):693-709. PubMed ID: 21835425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical overview of analytical methods for endocrine-disrupting compounds, pharmaceuticals and personal care products in water and wastewater.
    Comerton AM; Andrews RC; Bagley DM
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3923-39. PubMed ID: 19736228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approaches to trace analysis of pharmaceuticals and personal care products in the environment.
    Buchberger WW
    J Chromatogr A; 2011 Jan; 1218(4):603-18. PubMed ID: 21067760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risks associated with wastewater reuse and xenobiotics in the agroecological environment.
    Fatta-Kassinos D; Kalavrouziotis IK; Koukoulakis PH; Vasquez MI
    Sci Total Environ; 2011 Sep; 409(19):3555-63. PubMed ID: 20435343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
    Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
    J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence patterns of pharmaceuticals in water and wastewater environments.
    Nikolaou A; Meric S; Fatta D
    Anal Bioanal Chem; 2007 Feb; 387(4):1225-34. PubMed ID: 17205270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A pilot study for the assessment of pharmaceuticals as water contaminants].
    Bottoni P; Fidente R
    Ann Ist Super Sanita; 2005; 41(3):333-42. PubMed ID: 16552124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel analytical procedures for screening of drug residues in water, waste water, sediment and sludge.
    Buchberger WW
    Anal Chim Acta; 2007 Jun; 593(2):129-39. PubMed ID: 17543599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmaceuticals as pollution].
    Grung M; Langford K; Thomas KV
    Tidsskr Nor Laegeforen; 2012 May; 132(10):1249-51. PubMed ID: 22669389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration.
    Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JEM spotlight: recent advances in analysis of pharmaceuticals in the aquatic environment.
    Wong CS; MacLeod SL
    J Environ Monit; 2009 May; 11(5):923-36. PubMed ID: 19436850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
    Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
    Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and fate of emerging wastewater contaminants in Western Balkan Region.
    Terzić S; Senta I; Ahel M; Gros M; Petrović M; Barcelo D; Müller J; Knepper T; Martí I; Ventura F; Jovancić P; Jabucar D
    Sci Total Environ; 2008 Jul; 399(1-3):66-77. PubMed ID: 18420255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water.
    Mompelat S; Le Bot B; Thomas O
    Environ Int; 2009 Jul; 35(5):803-14. PubMed ID: 19101037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.